amoxapine has been researched along with Acute Confusional Senile Dementia in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Wang, Q | 1 |
| Hu, T | 1 |
| Wang, Y | 1 |
| Zhao, J | 1 |
| Lu, J | 1 |
| Pei, G | 1 |
1 other study available for amoxapine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets.
Topics: Alzheimer Disease; Amoxapine; Amyloid beta-Peptides; Antidepressive Agents, Tricyclic; beta-Arrestin | 2017 |